These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22096987)

  • 41. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice.
    Uppada SB; Bhat AA; Sah A; Donthamshetty RN
    Vaccine; 2011 Nov; 29(50):9352-60. PubMed ID: 22001881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.
    Demeure CE; Derbise A; Guillas C; Gerke C; Cauchemez S; Carniel E; Pizarro-Cerdá J
    Vaccine; 2019 Jan; 37(1):123-129. PubMed ID: 30467064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Yersinia pestis YadC: a novel vaccine candidate against plague.
    Murphy BS; Wulff CR; Garvy BA; Straley SC
    Adv Exp Med Biol; 2007; 603():400-14. PubMed ID: 17966436
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
    Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
    Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protection against Yersinia infection induced by non-virulence-plasmid-encoded antigens.
    Simonet M; Berche P; Mazigh D; Veron M
    J Med Microbiol; 1985 Oct; 20(2):225-31. PubMed ID: 3900406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Construction of defined F1 negative mutants of virulent Yersinia pestis.
    Worsham PL; Stein MP; Welkos SL
    Contrib Microbiol Immunol; 1995; 13():325-8. PubMed ID: 8833864
    [No Abstract]   [Full Text] [Related]  

  • 47. Humoral and cellular immune responses to Yersinia pestis Pla antigen in humans immunized with live plague vaccine.
    Feodorova VA; Lyapina AM; Khizhnyakova MA; Zaitsev SS; Sayapina LV; Arseneva TE; Trukhachev AL; Lebedeva SA; Telepnev MV; Ulianova OV; Lyapina EP; Ulyanov SS; Motin VL
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006511. PubMed ID: 29889829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice.
    Little SF; Webster WM; Wilhelm H; Fisher D; Norris SL; Powell BS; Enama J; Adamovicz JJ
    Vaccine; 2010 Jan; 28(4):934-9. PubMed ID: 19925906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infection.
    Hill J; Leary S; Smither S; Best A; Pettersson J; Forsberg A; Lingard B; Lipka A; Brown KA; Williamson ED; Titball RW
    Vaccine; 2009 Nov; 27(50):7073-9. PubMed ID: 19786138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis.
    Depaolo RW; Tang F; Kim I; Han M; Levin N; Ciletti N; Lin A; Anderson D; Schneewind O; Jabri B
    Cell Host Microbe; 2008 Oct; 4(4):350-61. PubMed ID: 18854239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
    Williamson ED; Flick-Smith HC; Waters E; Miller J; Hodgson I; Le Butt CS; Hill J
    Microb Pathog; 2007 Jan; 42(1):11-21. PubMed ID: 17107769
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cellular and humoral responses to microencapsulated Yersinia pestis subunit vaccines following oral delivery.
    Sharp GJ; Eyles JE; Williamson ED; Brown MR; Alpar HO
    Biochem Soc Trans; 1997 May; 25(2):338S. PubMed ID: 9191383
    [No Abstract]   [Full Text] [Related]  

  • 53. A live attenuated strain of Yersinia pestis ΔyscB provides protection against bubonic and pneumonic plagues in mouse model.
    Zhang X; Qi Z; Du Z; Bi Y; Zhang Q; Tan Y; Yang H; Xin Y; Yang R; Wang X
    Vaccine; 2013 May; 31(22):2539-42. PubMed ID: 23588087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinetic epitope mapping of monoclonal antibodies raised against the Yersinia pestis virulence factor LcrV.
    Read T; Olkhov RV; Williamson ED; Shaw AM
    Biosens Bioelectron; 2015 Mar; 65():47-53. PubMed ID: 25461137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibodies and cytokines independently protect against pneumonic plague.
    Kummer LW; Szaba FM; Parent MA; Adamovicz JJ; Hill J; Johnson LL; Smiley ST
    Vaccine; 2008 Dec; 26(52):6901-7. PubMed ID: 18926869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The characteristics of the action of the capsular antigen of Yersinia pestis on cells from plague-susceptible and -insusceptible rodents].
    Kagramanov VS; Aseeva LE; Varivoda TIu
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):13-6. PubMed ID: 10851982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Yersinia pestis and the plague.
    Rollins SE; Rollins SM; Ryan ET
    Am J Clin Pathol; 2003 Jun; 119 Suppl():S78-85. PubMed ID: 12951845
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunology of Yersinia pestis Infection.
    Bi Y
    Adv Exp Med Biol; 2016; 918():273-292. PubMed ID: 27722867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Deadly Path: Bacterial Spread During Bubonic Plague.
    Gonzalez RJ; Miller VL
    Trends Microbiol; 2016 Apr; 24(4):239-241. PubMed ID: 26875618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague.
    Vagima Y; Zauberman A; Levy Y; Gur D; Tidhar A; Aftalion M; Shafferman A; Mamroud E
    PLoS Pathog; 2015 May; 11(5):e1004893. PubMed ID: 25974210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.